Stock Option Linked to Consolidated Ordinary Profit
First written in FY2016. 17 of 24 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 April 2025 to 31 March 2026 Increase resulting from exercise of new share acquisition rights 50,000」
During the fiscal year, exercise of new share acquisition rights increased common shares by 50,000, while capital stock and capital surplus each increased by ¥16.300 million. - FY2025AdvancedAnnual report
「1 April 2024 to 31 March 2025 Increase resulting from exercise of new share acquisition rights 176,800」
In FY2025, exercise of new share acquisition rights increased common shares by 176,800, while capital stock and capital surplus each increased by ¥57.386 million. - FY2024AdvancedAnnual report
「1 April 2023 to 31 March 2024 Increase resulting from exercise of new share acquisition rights 192,400」
In FY2024, exercise of new share acquisition rights increased common shares by 192,400, while capital stock and capital surplus each increased by ¥62.722 million. - FY2024-Q2AdvancedAnnual report
「1 July 2023 to 30 September 2023 (Note) 2 24,400 47,570,100 7,954 3,833,729 7,954 3,243,729 (Note) 2. Increase resulting from the exercise of new share acquisition rights.」
During the second quarter accounting period, exercise of new share acquisition rights increased common shares by 24,400, while capital stock and capital surplus each increased by ¥7.954 million. - FY2024-Q1AdvancedAnnual report
「1 April 2023 to 30 June 2023 (Note) 48,000 47,515,700 15,648 3,796,989 15,648 3,206,989 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the first quarter, exercise of new share acquisition rights increased common shares by 48,000, while capital stock and capital surplus each increased by ¥15.648 million. - FY2023AdvancedAnnual report
「Resolution of the Board of Directors dated 28 February 2023 Category and number of eligible grantees (people) Company directors 4 Company senior employees 4 Number of new share acquisition rights (units) * 18,000 Class, details and number of shares underlying the new share acquisition rights (shares) * Common shares 1,800,000 Exercise period for the new share acquisition rights * 15 May 2023 to 1 March 2033」
The Company granted Series 18 stock options covering 1,800,000 shares to 4 directors and 4 senior employees. - FY2023-Q3AdvancedAnnual report
「1 October 2022 to 31 December 2022 (Note) 12,000 47,261,800 3,912 3,713,164 3,912 3,123,164 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the third quarter accounting period, exercise of new share acquisition rights increased common shares by 12,000, while capital stock and capital surplus each increased by ¥3.912 million. - FY2023-Q2AdvancedAnnual report
「1 July 2022 to 30 September 2022 (Note) 2 27,200 47,249,800 8,867 3,709,252 8,867 3,119,252 (Note) 2. Increase resulting from the exercise of new share acquisition rights.」
During the second quarter accounting period, exercise of new share acquisition rights increased common shares by 27,200, while capital stock and capital surplus each increased by ¥8.867 million. - FY2023-Q1AdvancedAnnual report
「1 April 2022 to 30 June 2022 (Note) 346,200 47,191,600 156,714 3,666,424 156,714 3,076,424 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the first quarter, exercise of new share acquisition rights increased common shares by 346,200, while capital stock and capital surplus each increased by ¥156.714 million. - FY2022-Q3AdvancedAnnual report
「At a meeting of the Board of Directors held on 28 January 2022, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue new share acquisition rights as share-price commitment stock options to the Company's directors (the "New Share Acquisition Rights").」
The Company disclosed a resolution to issue share-price commitment stock options covering 18,000 rights and 1,800,000 underlying shares to 4 directors. The exercise period is from 16 May 2022 to 11 October 2030. - FY2022-Q2AdvancedAnnual report
「1 July 2021 to 30 September 2021 (Note) 25,600 46,607,400 8,345 3,431,781 8,345 2,841,781 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the second quarter accounting period, exercise of new share acquisition rights increased common shares by 25,600, while capital stock and capital surplus each increased by ¥8.345 million. - FY2022-Q1AdvancedAnnual report
「1 April 2021 to 30 June 2021 852,000 46,581,800 325,783 3,423,436 325,783 2,833,436 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the first quarter, exercise of new share acquisition rights increased common shares by 852,000, while capital stock and capital surplus each increased by ¥325.783 million. - FY2021AdvancedAnnual report
「Exercise of new share acquisition rights increased the number of issued shares by 3,223,400, while capital stock and capital surplus each increased by ¥1,454.517 million.」
Exercise of new share acquisition rights increased the number of issued shares, capital stock and capital surplus. - FY2021-Q2AdvancedAnnual report
「1 July 2020 to 30 September 2020 (Note) 2,923,400 45,429,800 1,298,142 2,941,277 1,298,142 2,351,277 (Note) Increase resulting from the exercise of new share acquisition rights.」
During the second quarter accounting period, exercise of new share acquisition rights increased common shares by 2,923,400, while capital stock and capital surplus each increased by ¥1,298.142 million. - FY2021-Q1AdvancedAnnual report
「Exercise of new share acquisition rights from 1 July 2020 to 7 August 2020 was as follows.」
The exercise of 600 Series 11 new share acquisition rights resulted in the issuance of 240,000 common shares, while the exercise of 3,440 Series 15 new share acquisition rights resulted in the issuance of 688,000 common shares, increasing the total number of issued shares by 928,000. - FY2020RestatedAnnual report
「The holders of these new share acquisition rights (the "New Share Acquisition Rights Holders") may exercise the new share acquisition rights for the first time if ordinary profit in the consolidated income statement included in the financial results summaries filed by the Company for each consolidated fiscal year from the fiscal year ending March 2019 through the fiscal year ending March 2021 exceeds ¥3.1 billion.」
The exercise condition of ordinary profit exceeding ¥3.1 billion for the fiscal years ending March 2019 through March 2021 has been reconfirmed. - FY2020-Q2Update on the terms of issuance of new share acquisition rightsAnnual report
「Resolution date 30 August 2019 Category and number of eligible grantees (people) Company directors 4 Number of new share acquisition rights (units) * 270 Class, details and number of shares underlying the new share acquisition rights (shares) * Common shares 27,000 Exercise period for the new share acquisition rights * 21 September 2019 to 20 September 2049」
The Company issued 270 new share acquisition rights covering 27,000 underlying shares to 4 directors. The disclosed terms state that the exercise period is from 21 September 2019 to 20 September 2049, the rights may not be exercised while the holder is in office, and they may be exercised within 10 days after leaving office. - FY2019AdvancedAnnual report
「1 April 2018 to 31 March 2019 Increase resulting from exercise of new share acquisition rights 362,000」
In FY2019, exercise of new share acquisition rights increased the number of issued shares by 362,000, while capital stock and capital surplus each increased by ¥115.070 million. - FY2019-Q3AdvancedAnnual report
「27 December 2018 (Note) 353,600 42,498,000 112,400 1,640,465 112,400 1,050,465 (Note) Increase resulting from the exercise of new share acquisition rights.」
Exercise of new share acquisition rights increased the total number of issued shares by 353,600, while capital stock and capital surplus each increased by ¥112.400 million. - FY2019-Q1Issuance of share-price commitment stock optionsAnnual report
「At a meeting of the Board of Directors held on 27 June 2018, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue new share acquisition rights as share-price commitment stock options to the Company's directors and senior employees (the "New Share Acquisition Rights"), and issued them on 17 July 2018.」
The Company issued share-price commitment stock options covering 14,400 rights and 1,440,000 underlying shares to 4 directors and 5 senior employees. The conditions require all of the rights to be exercised if the average closing price falls below a price equal to 30% of the exercise price. - FY2018RestatedAnnual report
「The holders of these new share acquisition rights (the "New Share Acquisition Rights Holders") may exercise the new share acquisition rights for the first time if ordinary profit in the consolidated income statement included in the financial results summaries filed by the Company for each consolidated fiscal year from the fiscal year ending March 2019 through the fiscal year ending March 2021 exceeds ¥3.1 billion.」
The exercise condition of ordinary profit exceeding ¥3.1 billion for the fiscal years ending March 2019 through March 2021 has been reconfirmed. - FY2018-Q2Update on the terms of issuance of new share acquisition rightsAnnual report
「The new share acquisition rights issued during the second quarter accounting period are as follows. Number of new share acquisition rights (units) 130 Number of shares underlying the new share acquisition rights (shares) 13,000 Exercise period for the new share acquisition rights From 12 July 2017 To 11 July 2047 (1) The holders of the new share acquisition rights may not exercise them while serving as directors of the Company and may exercise them only during the period ending 10 days after the day following the date on which they cease to hold the position of director of the Company.」
During the second quarter accounting period, the Company issued 130 new share acquisition rights covering 13,000 underlying shares and disclosed a long exercise period and exercise conditions after a director leaves office. The cited passage does not state the threshold for consolidated ordinary profit. - FY2017RaisedAnnual report
「The holders of these new share acquisition rights (the "New Share Acquisition Rights Holders") may exercise the new share acquisition rights for the first time if ordinary profit in the consolidated income statement included in the financial results summaries filed by the Company for each consolidated fiscal year from the fiscal year ending March 2019 through the fiscal year ending March 2021 exceeds ¥3.1 billion.」
In addition to the previous ¥2 billion threshold, new share acquisition rights subject to a ¥3.1 billion threshold for the fiscal years ending March 2019 through March 2021 have been established for directors and employees. - FY2016First statedAnnual report
「The new share acquisition rights may be exercised if consolidated ordinary profit in the consolidated income statement included in the Company's securities report filed under the Financial Instruments and Exchange Act exceeds ¥2 billion.」
Consolidated ordinary profit of ¥2 billion has been set as an exercise condition for the new share acquisition rights for directors.